Who owns the MAX BIOPHARMA trademark?

The MAX BIOPHARMA trademark is owned by MAX BioPharma, Inc..

What class is the MAX BIOPHARMA trademark registered in?

The MAX BIOPHARMA trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for MAX BIOPHARMA?

The USPTO serial number for MAX BIOPHARMA is 98650750.

What is the registration number for MAX BIOPHARMA?

MAX BIOPHARMA is registered under USPTO registration number 7878149.

Sealvo

Home Search: MAX BIOPHARMAMAX BIOPHARMA #98650750

Back

Updated Oct 11, 2026·19 searches this week

View on USPTO TSDR Find similar marks

MAX

USPTO Trademark Record

REGISTERED

MAX BIOPHARMA

SN 98650750·Reg 7878149·Filed Jul 16, 2024

Owner MAX BioPharma, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MAX BIOPHARMA (Serial No. 98650750), Registration No. 7878149, is a registered US trademark filed on Jul 16, 2024 by MAX BioPharma, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: August 05, 2031

Mark Intelligence

MAX BIOPHARMA (Reg. #7878149) is a registered US trademark that has been protecting its owner, MAX BioPharma, Inc., since 2024. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 16, 2024

SERIAL

98650750

REG#

7878149

REGISTERED

Aug 05, 2025

Filing Information

StatusREGISTERED

Filing DateJul 16, 2024

Serial Number98650750

Registration No.7878149

Registration DateAug 05, 2025

Status DateAug 05, 2025

Published for OppositionJun 17, 2025

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 22, 2010

First use in commerce: Oct 22, 2010

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Aug 05, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 05, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jun 17, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 17, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 11, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 15, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 12, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 12, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 12, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

Apr 24, 2025

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

Apr 24, 2025

NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

Apr 24, 2025

NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 07, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 07, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 07, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Feb 09, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 09, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 09, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jan 28, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 15, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 16, 2024

NEW APPLICATION ENTERED

Other Marks by MAX BioPharma, Inc.

Additional USPTO filings from the same owner.

OXY

OXYSTEROL THERAPEUTICS

86746639

MAX BioPharma, Inc.

REGISTERED

OXY

OXYFUSE-133

98155706

MAX BioPharma, Inc.

ABANDONED

MAX

MAXBIOPHARMA

86746634

MAX BioPharma, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

HAN

HANSA BIOPHARMA

99652411

HANSA BIOPHARMA AB

REGISTERED

THE

THERAVANCE BIOPHARMA

79260681

Theravance Biopharma Ireland Limited

REGISTERED

HAN

HANSA BIOPHARMA

88196717

HANSA BIOPHARMA AB

REGISTERED

KED

KEDRION BIOPHARMA

79428966

KEDRION S.p.A.

REGISTERED

MAX BIOPHARMA

Run a conflict check

Other Marks by MAX BioPharma, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company